NIH study finds high rates of persistent chronic pain among U.S. adults

A 2023 NIH study found that 21% of US adults have chronic pain, and 8% have high-impact chronic pain. 

Estimates suggest that 20% of adults suffer from pain globally and 10% are newly diagnosed with chronic pain each year. (Centers for Disease Control and Prevention https://www.cdc.gov/nchs/data/databriefs/db390-H.pdf)

Data are the first nationwide estimates on the incidence of new chronic pain and new high impact chronic pain.

• The incidence of new chronic pain cases was high, at 52.4 cases per 1,000 persons per year. This is compared to other common chronic conditions, such as diabetes (7.1 cases/1,000 per year), depression (15.9 cases/ 1,000 per year), and hypertension (45.3 cases/1,000 per year).
• Among those who had reported non-chronic pain in 2019, about 1 in 6 (14.9%) said they had chronic pain in 2020, pointing to the importance of early management of pain.

         www.nih.gov

The prevalence of chronic pain was 20.4%, and the prevalence of high-impact chronic pain was 7.4% (or 36.4% of adults who had chronic pain). Chronic pain was highest among women (21.7%), non-Hispanic white adults (23.6%), and those aged 65 and over (30.8%). High impact chronic pain was highest among women (8.5%) and those aged 65 and over (11.8%)

Alejandro Pantoja, researcher and CEO of Alelicosmtics LLC, developed a product that relieves pain with 99% natural ingredients, one of them being Sacha Inchi, which contains omega-3: alpha linolenic acid (ALA), omega-6: linoleic acid (LA), omega-9: oleic acid (AO), omega-3 have anti-inflammatory properties.